EXECUTIVE ENGAGEMENTS
POOL
22039
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1984
Interactions with Platform & by Email
PARTICIPANTS
441
Unique # Participated
VALIDATIONS
96
Responses Validated*
COMPANIES
71
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
122
PAGES
208
EDITION
15
PRICE
USD 5600
CODE
MCP-6222
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for Clinical Trial Management Systems (CTMS) estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at aCAGR of 14.6% over the period 2020-2027. Enterprise-Wide CTMS, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Site CTMS segment is readjusted to a revised 13.3% CAGR for the next 7-year period.
The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$293.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$451.5 Million by the year 2027 trailing a CAGR of 14% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13% and 12.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.
SELECT PLAYERS
ArisGlobal LLC; BioClinica Inc.; Bio-Optronics Inc.; DSG Inc.; eResearch Technology Inc.; IBM Watson Health; Medidata Solutions; MedNet Solutions; Nextrials Inc.; Oracle Corp.; PAREXEL International Corp.; Trial By Fire Solutions LLC; Veeva Systems Inc.
SEGMENTS
» Deployment (Enterprise-Wide CTMS, On-Site CTMS) » Delivery Mode (Web-Based (On-Demand), Licensed Enterprise (On-Premise), Cloud (SaaS)) » End-Use (Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Clinical Trial Management Systems (CTMS) Gain Ground |
| Recent Market Activity |
| Benefits Offered by CTMS |
| Global Market Overview |
| Clinical Trial Management Systems Market to Post Explosive Growth |
| Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth |
| Key Players in the CTMS Market |
| Developed Countries Rule the Market |
| Pharmaceutical Firms and CROs to Drive Adoption Rate |
| Noteworthy Transformations in the Global Clinical Trial Sector |
| Clinical Trial Management Systems (CTMS) – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Clinical Trial Globalization Surges Demand for CTMS |
| 2. FOCUS ON SELECT PLAYERS |
| ArisGlobal, LLC (USA) |
| BioClinica, Inc. (USA) |
| Bio-Optronics, Inc. (USA) |
| DSG, Inc. (USA) |
| eResearch Technology, Inc. (USA) |
| IBM Watson Health (USA) |
| MedNet Solutions (USA) |
| Medidata Solutions (USA) |
| Nextrials, Inc. (USA) |
| Oracle Corp. (USA) |
| PAREXEL International Corp. (USA) |
| Trial By Fire Solutions, LLC (USA) |
| Veeva Systems, Inc. (USA) |
| Winchester Business Systems (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Surging Global Population Offers Increased Growth Opportunities |
| Increased Spend on R&D - An Important Growth Driver |
| CROs - The Targeted Customers for CTMS |
| Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand |
| CROs Adept with New Technologies to See More Business in Future |
| Rise in Clinical Trial Complexities Propels CTMS Demand |
| Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand |
| Adoption of Digital Technologies Gains Pace |
| Clinical Trial Operators Demand Efficient Data Management Platforms |
| DLB System’s Solution with Data Management Tools |
| Systems Integration Becomes Imperative |
| Technological Innovations Drive Market Growth |
| MC10 Introduces BioStampRC System to Capture Clinical Trial Data |
| UF Health Cancer Center Unveils OnCore® Clinical Trials Management System |
| UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Enterprise-Wide CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for On-Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Web-Based (On-demand) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cloud (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Large Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Clinical Trial Management Systems (CTMS) Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| JAPAN |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| CHINA |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| EUROPE |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| FRANCE |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| GERMANY |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com